Macrophages, as pivotal cells within the tumour microenvironment, significantly influence
the impact of and reactions to treatments for solid tumours. The rapid evolution of …

The limited bioavailability, susceptibility to degradation, and adverse side effects of novel
drugs often hinder their effective administration. Nanoparticles, with customizable properties …

The tumour‐targeting efficiency of systemically delivered chemodrugs largely dictates the
therapeutic outcome of anticancer treatment. Major challenges lie in the complexity of …

Microrobots have the potential for diverse applications, including targeted drug delivery and
minimally invasive surgery. Despite advancements in microrobot design and actuation …

The emergence of micro/nanorobotics stands poised to revolutionize various biomedical
applications, given its potential to offer precision, reduced invasiveness, and enhanced …

Macrophages, which are part of the mononuclear phagocytic system, possess sensory
receptors that enable them to target cancer cells. In addition, they are able to engulf large …

Nanocarriers are frequently used for drug delivery due to their large surface area,
biocompatibility, and photothermal effects. However, they face the problem of premature …

Cancer treatment requires precise tumor‐specific targeting at specific sites that allows for
high‐resolution diagnostic imaging and long‐term patient‐tailorable cancer therapy; while …

Magnetic robots possess an innate ability to navigate through hard-to-reach cavities in the
human body, making them promising tools for diagnosing and treating diseases minimally …

In the realm of thrombosis treatment, bioengineered outer membrane vesicles (OMVs) offer
a novel and promising approach, as they have rich content of bacterial‐derived components …